Cargando…
Persistent Antiphospholipid Antibodies Are Not Associated With Worse Clinical Outcomes in a Prospective Cohort of Hospitalised Patients With SARS-CoV-2 Infection
OBJECTIVE: Patients with COVID-19 presented with an elevated prevalence of antiphospholipid antibodies (aPL) but the relationship with thrombosis is controversial. We analysed the persistence of aPL and their association with the clinical outcomes during hospitalisation in a cohort of COVID-19 patie...
Autores principales: | Espinosa, Gerard, Zamora-Martínez, Carles, Pérez-Isidro, Albert, Neto, Daniela, Bravo-Gallego, Luz Yadira, Prieto-González, Sergio, Viñas, Odette, Moreno-Castaño, Ana Belen, Ruiz-Ortiz, Estíbaliz, Cervera, Ricard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257245/ https://www.ncbi.nlm.nih.gov/pubmed/35812410 http://dx.doi.org/10.3389/fimmu.2022.911979 |
Ejemplares similares
-
Beta‐2‐Glycoprotein‐I Deficiency Could Precipitate an Antiphospholipid Syndrome‐like Prothrombotic Situation in Patients With Coronavirus Disease 2019
por: Serrano, Manuel, et al.
Publicado: (2021) -
Antiphospholipid syndrome
por: Espinosa, Gerard, et al.
Publicado: (2008) -
Management of the antiphospholipid syndrome
por: Espinosa, Gerard, et al.
Publicado: (2010) -
The Catastrophic Antiphospholipid Syndrome
por: Rodríguez-Pintó, Ignasi, et al.
Publicado: (2014) -
COVID-19 and the antiphospholipid syndrome
por: Serrano, Manuel, et al.
Publicado: (2022)